Arkolith/Insider Trading/LYRA/Form 4

Anderson Edward T

Director, 10% OwnerLyra Therapeutics, Inc. (LYRA) · full profile →Form 4 · filed Apr 14, 2022
Net Buying
Open-Market Buys
$10.5M
Open-Market Sells
$0
Net Open-Market Flow
$10.5M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 12, 2022Buy(P)1.1M$4.22$4.5M1.9M
Apr 12, 2022Buy(P)118K$4.22$500K118K
Apr 12, 2022Buy(P)765K$4.22$3.2M1.3M
Apr 12, 2022Buy(P)528K$4.22$2.2M909K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-014794) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML